Budesonide | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Budesonide
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Coral Budesonide

Contact Supplier

dmfs-not-supported-m-2025-05-19

PharmaCompass Sponsored Ads

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Budesonide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

86 API Suppliers, 26 USDMF, 28 CEP/COS, 7 JDMF, 7 EU WC, 15 KDMF, 36 NDC API, 44 Listed Suppliers, $ API Reference Price

86 API Suppliers
26 USDMF
28 CEP/COS
7 JDMF
7 EU WC
15 KDMF
36 NDC API
44 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

79 Drugs in Development

79 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

637 FDF Dossiers, 54 FDA Orange Book, 429 Europe, 23 Canada, 19 Australia, 39 South Africa, 73 Listed Dossiers

637 FDF Dossiers
54 FDA Orange Book
429 Europe
23 Canada
19 Australia
39 South Africa
73 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

TABLET, EXTENDED RELEASE;ORAL - 9MG
AEROSOL, FOAM;RECTAL - 2MG/ACTUATION
SPRAY, METERED;NASAL - 0.032MG/SPRAY
SUSPENSION;INHALATION - 0.25MG/2ML
SUSPENSION;INHALATION - 0.5MG/2ML
SUSPENSION;INHALATION - 1MG/2ML
CAPSULE, DELAYED RELEASE;ORAL - 6MG
CAPSULE, DELAYED RELEASE;ORAL - 9MG
CAPSULE, DELAYED RELEASE;ORAL - 3MG
AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 13 DKSH, 4 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

69 Coating Systems & Additives, 63 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 37 Thickeners and Stabilizers, 25 Solubilizers, 22 Direct Compression, 21 Film Formers & Plasticizers, 20 Granulation, 19 Taste Masking, 18 Topical, 18 Lubricants & Glidants, 13 Parenteral, 11 Co-Processed Excipients, 10 Rheology Modifiers, 9 Emulsifying Agents, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

69 Coating Systems & Additives
63 Fillers, Diluents & Binders
41 Controlled & Modified Release
37 Thickeners and Stabilizers
25 Solubilizers
22 Direct Compression
21 Film Formers & Plasticizers
20 Granulation
19 Taste Masking
18 Topical
18 Lubricants & Glidants
13 Parenteral
11 Co-Processed Excipients
10 Rheology Modifiers
9 Emulsifying Agents
9 Empty Capsules
9 Disintegrants & Superdisintegrants
6 Chewable & Orodispersible Aids
5 Coloring Agents
5 API Stability Enhancers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 134 News #PharmaBuzz

1 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
134 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 232 Regulatory FDF Prices, 37 Annual Reports

5 US Medicaid Prescriptions
232 Regulatory FDF Prices
37 Annual Reports

MARKET PLACE

20 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

20 APIs
17 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

36 US Patents, 4 US Exclusivities, 2 Health Canada Patents

36 US Patents
4 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 21 USP, 13 Others

2 EDQM
21 USP
13 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,402 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 2CALLIDITAS

02 2TAKEDA PHARMS USA

filter Product Reset all filters

4 All

01 4BUDESONIDE

filter Exclusivity Expiration Date Reset all filters

4 All

01 12027-02-09

02 12028-12-15

03 12030-12-20

04 12031-02-09

filter Exclusivity Code Reset all filters

4 All

01 1NP

02 1ODE-389

03 1ODE-464

04 1ODE-466

Minakem Budesonide

Product Main Page

CALLIDITAS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-389

Exclusivity Expiration Date

2028-12-15

Application Number

215935

Product Number

1

Exclusivity Details

01

CALLIDITAS

Hospitalar

Not Confirmed

CALLIDITAS

Sweden

Hospitalar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-389

Exclusivity Expiration Date : 2028-12-15

Application Number : 215935

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-466

Exclusivity Expiration Date

2031-02-09

Application Number

213976

Product Number

1

Exclusivity Details

02

TAKEDA PHARMS USA

Hospitalar

Not Confirmed

TAKEDA PHARMS USA

Japan

Hospitalar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-466

Exclusivity Expiration Date : 2031-02-09

Application Number : 213976

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

NP

Exclusivity Expiration Date

2027-02-09

Application Number

213976

Product Number

1

Exclusivity Details

03

TAKEDA PHARMS USA

Hospitalar

Not Confirmed

TAKEDA PHARMS USA

Japan

Hospitalar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NP

Exclusivity Expiration Date : 2027-02-09

Application Number : 213976

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

CALLIDITAS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUDESONIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-464

Exclusivity Expiration Date

2030-12-20

Application Number

215935

Product Number

1

Exclusivity Details

04

CALLIDITAS

Hospitalar

Not Confirmed

CALLIDITAS

Sweden

Hospitalar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-464

Exclusivity Expiration Date : 2030-12-20

Application Number : 215935

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!